24/7 Market News Snapshot 04 March, 2025 – Neuronetics, Inc. Common Stock (NASDAQ:STIM)

March 4, 2025

DENVER, Colo., 04 March, 2025 (247marketnews.com) – (NASDAQ:STIM) are discussed in this article.
Neuronetics, Inc. has experienced a robust uptick in trading, starting at $4.35 and reaching $5.046, showcasing a notable increase of 18.45%. This surge comes on the heels of a previous closing price of $4.260, revealing strong investor interest. With current trading volumes hitting 2.61 million shares, the heightened activity suggests potential continued upward momentum for the stock. This significant price shift, coupled with high trading volume, may indicate a breakthrough from previous resistance levels. As market sentiment shifts, monitoring key technical indicators, such as moving averages and relative strength index (RSI), will be essential for evaluating future price trajectories and volatility.

In addition to its impressive market performance, Neuronetics announced significant financial and operational achievements for the fourth quarter and full year of 2024, emphasizing advancements in mental health treatment and overall company growth. The firm reported fourth-quarter revenues of $22.5 million, an 11% increase from the prior year’s fourth quarter. This growth is largely attributed to the strategic acquisition of Greenbrook TMS on December 9, 2024, which has bolstered Neuronetics’ market presence and accessibility to treatments. The immediate revenue benefit from Greenbrook amounted to $4.4 million generated from U.S. clinic sales within a brief operational window following the acquisition.

For the full year, Neuronetics recorded total revenues of $74.9 million, reflecting a 5% increase from 2023, further driven by effective integration and expansion of services. The company is optimistic about its future, projecting worldwide revenue between $145 million and $155 million for 2025, alongside aspirations for cash flow positivity by the third quarter of 2025. These forward-looking projections align with Neuronetics’ ongoing commitment to enhancing mental health treatment and operational efficacy.

Related news for (STIM)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.